Diagnosis of human immunodeficiency virus infection

BS Parekh, CY Ou, PN Fonjungo… - Clinical microbiology …, 2018 - Am Soc Microbiol
SUMMARY HIV diagnostics have played a central role in the remarkable progress in
identifying, staging, initiating, and monitoring infected individuals on life-saving antiretroviral …

[HTML][HTML] Technologies for HIV-1 drug resistance testing: inventory and needs

KJ Metzner - Current Opinion in HIV and AIDS, 2022 - journals.lww.com
The use of NGS technologies on HIV DR testing will allow unprecedented insights into
genomic structures of virus populations that may be of immediate relevance to both clinical …

Low-abundance drug-resistant HIV-1 variants in antiretroviral drug-naive individuals: a systematic review of detection methods, prevalence, and clinical impact

HA Mbunkah, S Bertagnolio, RL Hamers… - The Journal of …, 2020 - academic.oup.com
Background The presence of high-abundance drug-resistant HIV-1 jeopardizes success of
antiretroviral therapy (ART). Despite numerous investigations, the clinical impact of low …

HIV-1 genotypic drug resistance testing: digging deep, reaching wide?

K Van Laethem, K Theys, AM Vandamme - Current opinion in virology, 2015 - Elsevier
Highlights•Technological innovations enable the global roll-out of drug resistance
surveillance.•Next-generation sequencing provides an answer for simultaneous resistance …

Resistance of hepatitis C virus to inhibitors: complexity and clinical implications

C Perales, J Quer, J Gregori, JI Esteban, E Domingo - Viruses, 2015 - mdpi.com
Selection of inhibitor-resistant viral mutants is universal for viruses that display quasi-
species dynamics, and hepatitis C virus (HCV) is no exception. Here we review recent …

RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients

EK Alidjinou, J Deldalle, C Hallaert… - Journal of …, 2017 - academic.oup.com
Background Sanger sequencing of plasma RNA is the standard method for HIV-1 drug
resistance testing in treatment-naive patients, but is limited by the non-detection of …

Utility of metagenomic next-generation sequencing for characterization of HIV and human pegivirus diversity

KC Luk, MG Berg, SN Naccache, B Kabre… - PloS one, 2015 - journals.plos.org
Given the dynamic changes in HIV-1 complexity and diversity, next-generation sequencing
(NGS) has the potential to revolutionize strategies for effective HIV global surveillance. In …

HIV therapy—the state of art

D Looney, A Ma, S Johns - The Future of HIV-1 Therapeutics: Resistance …, 2015 - Springer
HIV Attachment. In this cross section, HIV is shown at the top and a target cell is shown at the
bottom in blues. HIV envelope protein (A) has bound to the receptor CD4 (B) and then to …

Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism …

N Silver, M Paynter, G McAllister, M Atchley… - AIDS research and …, 2018 - Springer
Background The widespread global access to antiretroviral drugs has led to considerable
reductions in morbidity and mortality but, unfortunately, the risk of virologic failure increases …

Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq

DM Dudley, AL Bailey, SH Mehta, AL Hughes, GD Kirk… - Retrovirology, 2014 - Springer
Background Viral resistance to antiretroviral therapy threatens our best methods to control
and prevent HIV infection. Current drug resistance genotyping methods are costly, optimized …